Cargando…
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells
Colorectal cancer is the third leading cancer worldwide. Although incidence and mortality of colorectal cancer are gradually decreasing in the US, patients with metastatic colorectal cancer have poor prognosis with an estimated 5-year survival rate of less than 10%. Over the past decade, advances in...
Autores principales: | Kim, Ji Sung, Kim, Yong Guk, Park, Eun Jae, Kim, Boyeong, Lee, Hong Kyung, Hong, Jin Tae, Kim, Youngsoo, Han, Sang-Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853502/ https://www.ncbi.nlm.nih.gov/pubmed/27162526 http://dx.doi.org/10.4110/in.2016.16.2.99 |
Ejemplares similares
-
Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015) -
Inhibition of Human Pancreatic Tumor Growth by Cytokine-Induced Killer Cells in Nude Mouse Xenograft Model
por: Kim, Ji Sung, et al.
Publicado: (2012) -
CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms
por: Lee, Hong Kyung, et al.
Publicado: (2017) -
Preclinical Efficacy and Mechanisms of Mesenchymal Stem Cells in Animal Models of Autoimmune Diseases
por: Lee, Hong Kyung, et al.
Publicado: (2014) -
Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2020)